Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2016 May 18.

Published in final edited form as: J Autism Dev Disord. 2012 Jul;42(7):1435–1445. doi: 10.1007/s10803-011-1378-7

Table 2. Comparison of reactivity to human and Rhesus brain protein.

Study population (n)	Original cohort		New cohort

	HFB 37 and 73 kDa	RFB 37 and 73 kDa	Study population (n)	RFB 37 and 73 kDa
AU (n = 61)	7 (12%)	7 (12%)	AU (n = 143)	10 (7%)
TD (n = 62)	0 (0%)	0 (0%)	TD (n = 121)	0 (0%)
DD (n = 40)	0 (0%)	0 (0%)	DD (n = 62)	0 (0%)
Significance (p value)
AU vs. TD	0.0061^*	0.0061^*		0.0022^*
AU vs. DD	0.0401^*	0.0401^*		0.0341^*
AU vs. Controls	0.0008^*	0.0008^*		0.0002^*
Odds Ratios (OR ± 95% CI)^**
AU vs. TD	17.2 (0.96–308)	17.2 (0.96–308)		17.8 (1.1–300)
AU vs. DD	9.9 (0.58–169)	9.9 (0.58–169)		9.2 (0.55–154)
AU vs. Controls	24.9 (1.45–429)	24.9 (1.45–429)		26.8 (1.6–454)

^*

For group comparisons, differences are considered significant at p < 0.05

^**

Significant differences yielded odds ratios and 95% CI